Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

Next Previous
Trial Profile

Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

Recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2018

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use

    • Most Recent Events

    • 06 Sep 2018 Status changed from not yet recruiting to recruiting.
    • 25 Apr 2018 Planned initiation date changed from 1 Apr 2018 to 1 Jul 2018.
    • 22 Jan 2018 Planned initiation date changed from 1 Oct 2017 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top